Tyra Biosciences (TYRA) Insider Trading & Ownership $15.87 -0.34 (-2.10%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tyra Biosciences (NASDAQ:TYRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$152,000.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$2.61 M Get TYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Tyra Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TYRA Insider Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Tyra Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/4/2024Nina S KjellsonDirectorSell1,076$17.01$18,302.76 11/1/2024Nina S KjellsonDirectorSell27,493$16.56$455,284.08 10/30/2024Alan FuhrmanCFOBuy9,500$16.00$152,000.00 10/30/2024Nina S KjellsonDirectorSell11,078$16.17$179,131.26 10/21/2024Todd HarrisCEOSell19,084$27.90$532,443.60 10/17/2024Todd HarrisCEOSell15,394$25.85$397,934.90 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/15/2024Todd HarrisCEOSell10,035$24.31$243,950.85 9/30/2024Todd HarrisCEOSell500$24.00$12,000.00 9/25/2024Todd HarrisCEOSell600$24.01$14,406.00 9/23/2024Todd HarrisCEOSell10,092$24.13$243,519.96 9/19/2024Todd HarrisCEOSell5,698$24.31$138,518.38 6/10/2024Daniel BensenCOOSell3,502$20.00$70,040.00 6/7/2024Daniel BensenCOOSell200$20.00$4,000.00 3/11/2024Daniel BensenCOOSell200$20.00$4,000.00 3/6/2024Daniel BensenCOOSell1,733$20.09$34,815.97 2/29/2024Daniel BensenCOOSell2,050$20.00$41,000.00 2/27/2024Daniel BensenCOOSell745$20.00$14,900.00 2/12/2024Daniel BensenCOOSell1,501$20.00$30,020.00 2/7/2024Daniel BensenCOOSell9,587$18.09$173,428.83 (Data available from 1/1/2013 forward) TYRA Insider Trading Activity - Frequently Asked Questions Who is on Tyra Biosciences's Insider Roster? The list of insiders at Tyra Biosciences includes Alan Fuhrman, Boxer Capital, Llc, Daniel Bensen, Mva Investors, Llc, Nina S Kjellson, and Todd Harris. Learn more on insiders at TYRA. What percentage of Tyra Biosciences stock is owned by insiders? 15.40% of Tyra Biosciences stock is owned by insiders. Learn more on TYRA's insider holdings. Which Tyra Biosciences insiders have been buying company stock? The following insider purchased TYRA shares in the last 24 months: Alan Fuhrman ($152,000.00). How much insider buying is happening at Tyra Biosciences? Insiders have purchased a total of 9,500 TYRA shares in the last 24 months for a total of $152,000.00 bought. Which Tyra Biosciences insiders have been selling company stock? The following insiders have sold TYRA shares in the last 24 months: Daniel Bensen ($1,410,425.52), Mva Investors, Llc ($2,620,000.00), Nina S Kjellson ($652,718.10), and Todd Harris ($2,146,820.44). How much insider selling is happening at Tyra Biosciences? Insiders have sold a total of 418,119 Tyra Biosciences shares in the last 24 months for a total of $6,829,964.06 sold. Tyra Biosciences Key ExecutivesDr. Todd Harris Ph.D. (Age 45)Co-Founder, President, CEO, Secretary, Treasurer & Director Compensation: $1.07MMr. Alan Fuhrman (Age 67)Chief Financial Officer Compensation: $763.09k1 recent tradesDr. Hiroomi Tada M.D. (Age 60)Ph.D., Chief Medical Officer Compensation: $816.31kMr. Daniel Bensen (Age 48)Co-Founder & COO Compensation: $630.8k2 recent tradesDr. Robert L. Hudkins Ph.D. (Age 68)Chief Technology Officer Dr. Ronald V. Swanson Ph.D. (Age 60)Chief Scientific Officer Compensation: $536.19kMr. Ali D. Fawaz J.D.General CounselMs. Sarah HonigVice President of Corporate Development & StrategyDr. Piyush R. Patel Ph.D. (Age 58)Chief Development Officer Amy ConradInvestor Contact More Insider Trading Tools from MarketBeat Related Companies MLTX Insider Trades AGIO Insider Trades DYN Insider Trades VRNA Insider Trades PTCT Insider Trades EWTX Insider Trades BHC Insider Trades MRUS Insider Trades XENE Insider Trades VERA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:TYRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
